Key points are not available for this paper at this time.
Objectives We aimed to analyse the highly-cited papers on COVID-19 research from Bangladesh. This study used bibliometric methods to examine the characteristics and trends of COVID-19 research in the country. Material and Methods To source publication data for the study, the Scopus database was used, until 26th July 2023, employing a specific search strategy. The search yielded 4124 papers, which were then rearranged based on the frequency of citations to obtain the highly cited papers (HCPs), which received 100 or more citations. Results The 110 (2.67%) HCPs registered citations ranging from 100 to 1502, with an average of 236.21 Citations per Paper (CPP). Only 30.9% of the publications received external funding and and received an average CPP of 332.0. Similarly, 80% of the HCPs were involved in international collaboration, and and received an average of 249.89 CPP. The major international contributors were the USA, Australia, U.K., and China. The most productive organisations were Jahangirnagar University, International Centre for Diarrhoeal Disease Research, and University Of Dhaka. The most impactful organisations were Neurogen Children’s Healthcare, Bangabandhu Sheikh Mujib Medical University, and Begum Rokeya University. Three most productive authors were Mamun, M.A. (n=8), Saiful Islam, M. (n=6), Tajuddin Sikder, Md. and Bodrud-Doza, Md. (n=4 each). Conclusion This study provides the current status of research on COVID-19, including its trends and the most significant contributions from Bangladesh. It has highlighted the top authors, organisations, journals, and research hotspots in the field of COVID-19 research. This information can also help researchers identify potential collaborators, relevant papers, and important research questions in their areas of expertise.
Vaishya et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: